Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Biofactors (Oxford, England)|March 19, 2021
Berberine ameliorates neuronal AD-like change via activating Pi3k/PGCε pathwayNinghua Wu, Wu Liu, Jiawen Wang, et al.
Discover Oncology|May 18, 2023
Depiction of neuroendocrine features associated with immunotherapy response using a novel one-class predictor in lung adenocarcinomaHao Liu, Yan Han, Zhantao Liu, et al.
Biochemical and Biophysical Research Communications|July 16, 2017
Overexpression of Pofut1 and activated Notch1 may be associated with poor prognosis in breast cancerGuoxing Wan, Lin Tian, Yuandong Yu, et al.
DNA and Cell Biology|September 7, 2021
HNRNPL Is Identified and Validated as a Prognostic Biomarker Associated with Microsatellite Instability in Human Gastric CancerXiongjie Yu, Fengjun Cao, Yuandong Yu, et al.
Nature and Science of Sleep|December 3, 2025
The Associations Between Depression, Subjective Sleep Quality, and Health-Related Quality of Life in Patients with Meige Syndrome: A Cross-Sectional StudyMeng Li, Jianhua Li, Mengtian Li, et al.
Frontiers in Immunology|March 16, 2026
Sex-based heterogeneity in response to first-line immunotherapy plus chemotherapy in advanced esophageal squamous-cell carcinoma: a meta-analysisKai Yang, Wei Shang, Lu Wang, et al.
Cellular & Molecular Immunology|October 26, 2019
Macrophages reprogrammed by lung cancer microparticles promote tumor development via release of IL-1βJie Chen, Weiwei Sun, Huafeng Zhang, et al.
Oncoimmunology|July 7, 2017
Chemotherapeutic tumor microparticles combining low-dose irradiation reprogram tumor-promoting macrophages through a tumor-repopulating cell-curtailing pathwayYanling Sun, Zu'an Zheng, Huafeng Zhang, et al.
Cancer Immunology Research|July 14, 2018
Circulating Tumor Microparticles Promote Lung Metastasis by Reprogramming Inflammatory and Mechanical Niches via a Macrophage-Dependent PathwayHuafeng Zhang, Yuandong Yu, Li Zhou, et al.
Redox Biology|November 16, 2018
Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-γ in colon cancerYunYan Tai, Fengjun Cao, Mingxing Li, et al.
Pageof 3